Lactobacillus Plantarum for Anti-Inflammatory

Research suggests that Lactobacillus plantarum may exert anti-inflammatory effects through several distinct biological pathways, including the modulation of macrophage behavior, production of bioactive metabolites, release of extracellular vesicles, and influence on gut nervous system signaling. The bulk of the available evidence comes from laboratory cell studies and animal models — particularly mouse models of colitis and skin inflammation — with one randomized controlled trial in stressed adults showing shifts toward a less inflammatory immune profile alongside reduced cortisol and improved psychological measures. Studies indicate that the bacterium and its byproducts, including extracellular vesicles, short proteins, and metabolites such as indole-3-lactic acid and gamma-ketoC, can reduce levels of pro-inflammatory signaling molecules like TNF-α, IL-6, and IL-1β in experimental settings, though several of the included studies were neutral in direction, focusing on characterization or probiotic viability rather than inflammation outcomes directly. The evidence base is largely preclinical, and while findings are generally supportive, the diversity of strains studied, the predominance of animal and cell-culture models, and the limited number of human trials mean that broader conclusions about anti-inflammatory effects in people should be drawn cautiously.